Literature DB >> 11208670

Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons.

E López1, C Arce, S Vicente, M J Oset-Gasque, M P González.   

Abstract

Nicotine stimulation of cortical neurons obtained from gestation day 19 rats provoked a dose-dependent release of aspartate, glutamate, glycine and GABA, indicating a functional role for the nicotinic receptor in this model. This release was exclusively Ca2+-dependent (vesicular release) in the case of aspartate and dual Ca2+-dependent and Ca2+-independent) for glutamate, glycine and GABA. Nicotine also raised the membrane potential and the intracellular calcium concentration. These effects were specific, since they were reversed by hexamethonium, an antagonist of the nicotinic receptor. It was shown that L, N, and P/Q type Ca2+ channels are involved in nicotine-mediated Ca2+ entry into cortical neurons. Evaluation of the effects of nicotine on Ca2+ entry in isolated cells showed that 100% of the cells responded to nicotine, although the intensity of the response was variable: 63% of the neurons showed an increase in intracellular Ca(2+) of 152 +/- 5 grey levels, 25% of 88 +/- 12 grey levels and 12% of 48 +/- 1 grey levels. Tetrodotoxin, which blocks voltage-dependent Na(+) channels, completely reversed nicotine-induced Ca2+ entry into single cells. This suggests that the Ca2+ increment is mediated by opening of Ca2+ channels and not by the nicotinic receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208670     DOI: 10.1093/cercor/11.2.158

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  9 in total

1.  Nicotine exposure does not alter plasma to brain choline transfer.

Authors:  Paul R Lockman; Julie Gaasch; Ghia McAfee; Thomas J Abbruscato; Cornelis J Van der Schyf; David D Allen
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

2.  Functional characterization of intrinsic cholinergic interneurons in the cortex.

Authors:  Jakob von Engelhardt; Marina Eliava; Axel H Meyer; Andrei Rozov; Hannah Monyer
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

3.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

4.  Attention-enhancing effects of propranolol and synergistic effects with nicotine.

Authors:  Britta Hahn; Cory K Olmstead; Marie B Yuille; Joshua J Chiappelli; Ashleigh K Wells
Journal:  Cogn Affect Behav Neurosci       Date:  2020-06       Impact factor: 3.282

5.  The influence of a chronic adolescent nicotine exposure on ethanol withdrawal severity during adulthood in C3H mice.

Authors:  Hugh H Riley; André W Zalud; Jaime L Diaz-Granados
Journal:  Alcohol       Date:  2010-02       Impact factor: 2.405

6.  Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.

Authors:  Asa Konradsson-Geuken; Clelland R Gash; Kathleen Alexander; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; John P Bruno
Journal:  Synapse       Date:  2009-12       Impact factor: 2.562

Review 7.  Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Authors:  Francesca M Notarangelo; Ana Pocivavsek
Journal:  Neuropharmacology       Date:  2016-03-02       Impact factor: 5.250

Review 8.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

9.  Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder.

Authors:  Guillaume L Poirier; Wei Huang; Kelly Tam; Joseph R DiFranza; Jean A King
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.